Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strattec Security (STRT) Cash & Equivalents (2016 - 2025)

Strattec Security (STRT) has disclosed Cash & Equivalents for 16 consecutive years, with $99.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 132.32% to $99.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $99.0 million, a 132.32% increase, with the full-year FY2025 number at $84.6 million, up 232.86% from a year prior.
  • Cash & Equivalents was $99.0 million for Q4 2025 at Strattec Security, up from $90.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $99.0 million in Q4 2025 to a low of $7.0 million in Q3 2021.
  • A 5-year average of $30.2 million and a median of $15.1 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 41.38% in 2021, then skyrocketed 547.34% in 2025.
  • Strattec Security's Cash & Equivalents stood at $14.1 million in 2021, then dropped by 26.59% to $10.3 million in 2022, then grew by 12.05% to $11.6 million in 2023, then surged by 268.25% to $42.6 million in 2024, then surged by 132.32% to $99.0 million in 2025.
  • Per Business Quant, the three most recent readings for STRT's Cash & Equivalents are $99.0 million (Q4 2025), $90.5 million (Q3 2025), and $84.6 million (Q2 2025).